A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Exact Sciences Corp stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 49,388 shares of EXAS stock, worth $2.54 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
49,388
Holding current value
$2.54 Million
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$41.33 - $74.26 $2.04 Million - $3.67 Million
49,388 New
49,388 $2.09 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.08B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Portfolio

Follow Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund), based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) with notifications on news.